Commentary on Ji et al: Sub-optimal illustration of response adaptive randomization

Abstract

Get full access to this article

View all access options for this article.

References

McShane

Krailo

, et al. Bias in retrospective analyses of biomarker effect using data from outcome-adaptive randomized trial. Clin Trials 2019, this issue.

Hey

Kimmelman

Are outcome-adaptive allocation trials ethical?

Clin Trials 2015; 12(2): 102–106.

Berry

DA.

Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 107–109.

Lee

JJ.

Commentary on Hey and Kimmelman. Clin Trials 2015; 12(2): 110–112.

Korn

Freidlin

Outcome-adaptive randomization: is it useful?

J Clin Oncol 2011; 29(6): 771–776.

Thall

Fox

Wathen

Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials. Ann Oncol 2015; 26(8): 1621–1628.

Berry

DA.

Adaptive clinical trials: the promise and the caution. J Clin Oncol 2011; 29(6): 606–609.

Barker

Sigman

Kelloff

, et al. I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther 2009; 86(1): 97–100.

Berry

DA.

Adaptive clinical trials in oncology. Nat Revi Clin Oncol 2012; 9(4): 199–207.